Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 07:30PM GMT
Release Date Price: €104.1 (-1.89%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley.

It's my pleasure to have Tandem Diabetes with us today; John Sheridan, President and CEO; and Leigh Vosseller, EVP and CFO.

Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. (Operator Instructions)

And with that, John, Leigh, thank you both for joining us today.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thank you for having us. It's nice to be here.

Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot